TBRGMay 26, 2026 at 2:27 AM UTCHealth Care Equipment & Services

TruBridge Faces Securities Investigation Amid Mixed Financial Signals

Read source article

What happened

Rosen Law Firm has announced an investigation into TruBridge for possible materially misleading business information, adding legal risk to a company already navigating internal control weaknesses and elevated leverage. The investigation follows a period where TruBridge reported improving execution—94% recurring revenue, a 19% Adjusted EBITDA margin, and positive free cash flow—but also disclosed year-over-year bookings declines and persistent control issues. The company's guidance for FY2025 remains intact, with revenue of $345–$348 million and Adjusted EBITDA of $65–$68 million, yet the valuation appears full at an EV/EBITDA of ~13x and well above the DCF anchor. The DeepValue report had already flagged watch items including deleveraging, control remediation, and bookings re-acceleration, and now the investigation adds another layer of uncertainty. The net effect is increased downside risk until the investigation's scope and potential penalties are clearer, particularly given the company's restrictive credit agreement and limited financial flexibility.

Implication

The Rosen investigation introduces material litigation risk that could distract management and weigh on sentiment, especially given the company's history of control weaknesses. While TruBridge's operational metrics show improvement, the investigation suggests that prior disclosures may have been misleading, potentially impairing trust and making it harder to sustain guidance. Financially, any settlement or legal costs would pressure an already leveraged balance sheet (Net Debt/EBITDA 4.65x), and covenant compliance could become more challenging. Valuation at ~13x EV/EBITDA leaves little room for error; if the investigation leads to guidance cuts or client attrition, a significant de-rating is possible. Long-term investors need to see the investigation resolved without material financial or reputational damage, and clear evidence of control remediation and bookings acceleration before re-entering.

Thesis delta

The pre-existing 'WAIT' thesis is now tested by a securities investigation that undermines confidence in management's representations. The watch items of control remediation and booking trends become even more critical, but the immediate risk skews negatively until the investigation's outcome is known. The thesis shifts from a cautious hold to a near-term sell on legal overhang, though fundamental execution could prove the investigation unfounded.

Confidence

medium